STOCK TITAN

[144] Innovative Eyewear, Inc. Series A Warrants 8/16/27 SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Form 144 notice for Innovative Eyewear, Inc. (ticker LUCYW) shows a proposed sale of 1,670 common shares through Raymond James on 08/19/2025 on NASDAQ with an aggregate market value of $3,317.35. The filing reports the securities were acquired as an RSU grant from the issuer on 08/19/2025, with 5,400 units acquired and payment marked as cash. The issuer’s total shares outstanding are listed as 4,574,602. The filer certifies they are not aware of undisclosed material adverse information and indicates no securities sold in the prior three months.

Avviso Form 144 per Innovative Eyewear, Inc. (ticker LUCYW) indica una proposta di vendita di 1.670 azioni ordinarie tramite Raymond James il 08/19/2025 sul NASDAQ per un valore di mercato complessivo di $3.317,35. La dichiarazione riporta che i titoli sono stati acquisiti come assegnazione di RSU dall'emittente il 08/19/2025, con 5.400 unità acquisite e pagamento indicato in contanti. Le azioni in circolazione dell'emittente sono elencate in totale come 4.574.602. Il dichiarante certifica di non essere a conoscenza di informazioni negative rilevanti non divulgate e indica che non sono state vendute azioni nei tre mesi precedenti.

Aviso Formulario 144 para Innovative Eyewear, Inc. (símbolo LUCYW) muestra una propuesta de venta de 1.670 acciones ordinarias a través de Raymond James el 08/19/2025 en NASDAQ por un valor de mercado agregado de $3,317.35. La presentación declara que los valores fueron adquiridos como una concesión de RSU del emisor el 08/19/2025, con 5.400 unidades adquiridas y pago marcado como efectivo. Las acciones en circulación del emisor se listan en 4.574.602. El declarante certifica que no tiene conocimiento de información adversa material no divulgada e indica que no se vendieron valores en los tres meses anteriores.

Innovative Eyewear, Inc. (티커 LUCYW)용 Form 144 통지는 NASDAQ에서 08/19/2025에 Raymond James를 통해 1,670 보통주를 매각할 예정이며 총 시장가치는 $3,317.35라고 보고합니다. 제출서류에 따르면 해당 증권은 발행사로부터 RSU 부여08/19/2025에 취득되었고, 5,400 단위가 취득되었으며 결제 수단은 현금으로 표시되어 있습니다. 발행사의 총 발행주식수는 4,574,602로 기재되어 있습니다. 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 인증하며, 지난 세 달 동안 매도한 증권이 없음을 표시합니다.

Avis Formulaire 144 pour Innovative Eyewear, Inc. (symbole LUCYW) indique une proposition de vente de 1 670 actions ordinaires via Raymond James le 08/19/2025 sur le NASDAQ pour une valeur marchande totale de 3 317,35 $. Le dépôt rapporte que les titres ont été acquis sous forme d'attribution de RSU de l'émetteur le 08/19/2025, avec 5 400 unités acquises et le paiement indiqué en espèces. Le nombre total d'actions en circulation de l'émetteur est indiqué à 4 574 602. Le déclarant certifie qu'il n'a pas connaissance d'informations défavorables importantes non divulguées et indique qu'aucun titre n'a été vendu au cours des trois derniers mois.

Form 144-Mitteilung für Innovative Eyewear, Inc. (Ticker LUCYW) weist einen geplanten Verkauf von 1.670 Stammaktien über Raymond James am 08/19/2025 an der NASDAQ mit einem Gesamtmarktwert von $3.317,35 aus. Die Einreichung berichtet, dass die Wertpapiere als RSU-Zuteilung vom Emittenten am 08/19/2025 erworben wurden, wobei 5.400 Einheiten erhalten und die Zahlung als Bargeld gekennzeichnet wurde. Die insgesamt ausstehenden Aktien des Emittenten sind mit 4.574.602 angegeben. Der Einreicher bestätigt, dass ihm keine nicht offengelegten wesentlichen negativen Informationen bekannt sind, und gibt an, in den vorangegangenen drei Monaten keine Wertpapiere verkauft zu haben.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine small insider sale disclosed; transaction size is immaterial to company capitalization.

The filing documents a small proposed sale of 1,670 common shares valued at $3,317.35, originating from RSUs granted and acquired on the same date as the planned sale. Given the issuer's outstanding share count of 4,574,602, the transaction represents a negligible portion of equity and is unlikely to move market valuation. The report appears compliant with Rule 144 disclosure requirements and contains no indicators of material, nonpublic developments.

TL;DR: Disclosure aligns with insider selling rules; signer affirms no undisclosed material information.

The notice properly identifies the broker, planned sale date, and the RSU origin of the shares, and includes the required representation about material nonpublic information. The filing shows no prior sales in the past three months, which is relevant for aggregation rules. This is a routine Section 144 filing and raises no governance red flags based on the provided information.

Avviso Form 144 per Innovative Eyewear, Inc. (ticker LUCYW) indica una proposta di vendita di 1.670 azioni ordinarie tramite Raymond James il 08/19/2025 sul NASDAQ per un valore di mercato complessivo di $3.317,35. La dichiarazione riporta che i titoli sono stati acquisiti come assegnazione di RSU dall'emittente il 08/19/2025, con 5.400 unità acquisite e pagamento indicato in contanti. Le azioni in circolazione dell'emittente sono elencate in totale come 4.574.602. Il dichiarante certifica di non essere a conoscenza di informazioni negative rilevanti non divulgate e indica che non sono state vendute azioni nei tre mesi precedenti.

Aviso Formulario 144 para Innovative Eyewear, Inc. (símbolo LUCYW) muestra una propuesta de venta de 1.670 acciones ordinarias a través de Raymond James el 08/19/2025 en NASDAQ por un valor de mercado agregado de $3,317.35. La presentación declara que los valores fueron adquiridos como una concesión de RSU del emisor el 08/19/2025, con 5.400 unidades adquiridas y pago marcado como efectivo. Las acciones en circulación del emisor se listan en 4.574.602. El declarante certifica que no tiene conocimiento de información adversa material no divulgada e indica que no se vendieron valores en los tres meses anteriores.

Innovative Eyewear, Inc. (티커 LUCYW)용 Form 144 통지는 NASDAQ에서 08/19/2025에 Raymond James를 통해 1,670 보통주를 매각할 예정이며 총 시장가치는 $3,317.35라고 보고합니다. 제출서류에 따르면 해당 증권은 발행사로부터 RSU 부여08/19/2025에 취득되었고, 5,400 단위가 취득되었으며 결제 수단은 현금으로 표시되어 있습니다. 발행사의 총 발행주식수는 4,574,602로 기재되어 있습니다. 제출인은 공개되지 않은 중대한 불리한 정보가 없음을 인증하며, 지난 세 달 동안 매도한 증권이 없음을 표시합니다.

Avis Formulaire 144 pour Innovative Eyewear, Inc. (symbole LUCYW) indique une proposition de vente de 1 670 actions ordinaires via Raymond James le 08/19/2025 sur le NASDAQ pour une valeur marchande totale de 3 317,35 $. Le dépôt rapporte que les titres ont été acquis sous forme d'attribution de RSU de l'émetteur le 08/19/2025, avec 5 400 unités acquises et le paiement indiqué en espèces. Le nombre total d'actions en circulation de l'émetteur est indiqué à 4 574 602. Le déclarant certifie qu'il n'a pas connaissance d'informations défavorables importantes non divulguées et indique qu'aucun titre n'a été vendu au cours des trois derniers mois.

Form 144-Mitteilung für Innovative Eyewear, Inc. (Ticker LUCYW) weist einen geplanten Verkauf von 1.670 Stammaktien über Raymond James am 08/19/2025 an der NASDAQ mit einem Gesamtmarktwert von $3.317,35 aus. Die Einreichung berichtet, dass die Wertpapiere als RSU-Zuteilung vom Emittenten am 08/19/2025 erworben wurden, wobei 5.400 Einheiten erhalten und die Zahlung als Bargeld gekennzeichnet wurde. Die insgesamt ausstehenden Aktien des Emittenten sind mit 4.574.602 angegeben. Der Einreicher bestätigt, dass ihm keine nicht offengelegten wesentlichen negativen Informationen bekannt sind, und gibt an, in den vorangegangenen drei Monaten keine Wertpapiere verkauft zu haben.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for LUCYW disclose?

The Form 144 discloses a proposed sale of 1,670 common shares on 08/19/2025 via Raymond James, with aggregate market value of $3,317.35.

How were the shares to be sold for LUCYW acquired?

The shares were acquired as an RSU grant from the issuer on 08/19/2025, listing 5,400 units acquired and payment noted as cash.

On which exchange will the LUCYW shares be sold?

The filing states the sale is to occur on NASDAQ.

Does the Form 144 report any sales in the past three months for the filer?

The filing indicates "Nothing to Report" for securities sold during the past three months.

What is the issuer's total shares outstanding reported in the filing?

The filing lists 4,574,602 shares outstanding.
INNOVATIVE EYEWEAR INC

NASDAQ:LUCYW

LUCYW Rankings

LUCYW Latest News

LUCYW Latest SEC Filings

LUCYW Stock Data

2.00M
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
MIAMI